IOL injector and portable tonometer

Article

The AutoSert, launched by Alcon at the 2012 ESCRS in Milan, is an original automated lens insertion device that can be used through small incisions…

The AutoSert, launched by Alcon at the 2012 ESCRS in Milan, is an original automated lens insertion device that can be used through small incisions.

Professor Rob Osher spoke to OTEurope and shared his experience with the new device. "The device facilitates implantation through a small incision so the surgeon can use counter traction with his free hand whilst the insertion is completed with a footswitch."The IOL injector is consistent and enhances surgical control of the IOL. The insertion can be done single-handedly and the foot pedal allows the surgeons to perform better globe stabilization.

Alcon has developed the injector so it reduces wound stretching and minimized wound disruption and trauma.Professor Osher also mentioned Alcon,s iCare, a portable tonometer, "The iCare permits the patient to accurately measure the intraocular pressure on the evening of surgery. This device can quickly differentiate elevated intraocular pressure from other causes of postoperative pain. Moreover, it is very applicable in high-risk patients undergoing cataract surgery who have a pre-disposition to a pressure spike."

To find out more about the AutoSert and the iCare please visit www.alcon.com

Please note this product may not be FDA-approved for the US.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.